Is ferritin an acute-phase reactant that rises with inflammation independent of total body iron stores?

Ferritin is a critical biomarker whose utility is heavily influenced by systemic physiological states, particularly inflammation. In clinical practice, it is fundamentally recognized as an acute-phase reactant (APR), a protein whose serum concentration increases significantly—often by 25% or more—in response to infection, malignancy, or autoimmune conditions.

Clinical and effectiveness evidence

In patients with chronic inflammatory diseases, such as rheumatoid arthritis, heart failure, or chronic kidney disease, serum ferritin levels frequently dissociate from actual total body iron stores. Studies demonstrate that while a ferritin level below 30 µg/L is highly specific for iron deficiency in healthy individuals, this threshold must often be raised to 100 µg/L or higher in inflammatory states to maintain diagnostic sensitivity. This elevation can mask true iron deficiency, leading to "functional iron deficiency" where ferritin appears normal or high despite a lack of iron available for erythropoiesis.

Mechanistic explanations

The rise of ferritin during inflammation is driven by two primary pathways:

• Direct Cytokine Induction: Pro-inflammatory cytokines, specifically Interleukin-6 (IL-6), activate the JAK-STAT3 signaling pathway. This leads to the phosphorylation and nuclear translocation of STAT3, which binds directly to the ferritin heavy chain (FTH) gene promoter, upregulating transcription regardless of iron status.
• Hepcidin-Mediated Sequestration: Inflammation triggers the production of hepcidin, which blocks ferroportin, the primary iron exporter. This traps iron within macrophages and enterocytes, inducing intracellular ferritin synthesis to store the sequestered iron. This serves as an "iron-withholding" innate immune strategy to starve invading pathogens of necessary iron.

Bottom line

Ferritin is a definitive acute-phase reactant. Its synthesis is directly up-regulated by IL-6 and other cytokines, causing serum levels to rise during inflammation even if total body iron stores are low or depleted. This makes Ferritin a "masked" marker in inflammatory contexts, necessitating higher diagnostic cut-offs for iron deficiency.